Madagascar

in page functions
[French]
Madagascar
Total population (2018) 26,326,236
Birth cohort (2018) 882,432
Surviving Infants (surviving to 1 year per year, 2018) 856,746
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 36/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 50/1000
World Bank Index, IDA (2015) 3.14
Gross Nation Income (per capita US$, 2015) 420
No. of districts/territories (2017) 114

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Madagascar

Type of support

Approvals

2001-2023 (US$)
(2 Jul 2019)

Commitments

2001-2023 (US$)
(2 Jul 2019)

Disbursements

2000-2019 (US$)
(2 Jul 2019)

% Disbursed

(2 Jul 2019)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $201,962,328 $207,239,106 $202,472,078
Cash Support (CASHSUPP) $177,500 $177,500 $177,500 100%
Cold Chain Equipment Optimisation Platform (CCEOP) $3,597,780 $3,597,780 $3,597,550 100%
Health system strengthening (HSS 1) $10,936,770 $10,936,770 $12,118,057 111%
Health system strengthening (HSS 2) $11,739,852 $17,016,630 $6,372,841 54%
HPV Demo (NVS) $247,348 $247,348 $247,348 100%
Immunisation services support (ISS) $4,064,400 $4,064,400 $4,064,400 100%
Injection Safety Devices (NVS) $727,160 $727,160 $586,527 81%
Injection safety support (INS) $615,555 $615,555 $615,555 100%
IPV (NVS) $7,892,829 $7,892,829 $6,936,903 88%
Measles 1st and 2nd dose (NVS) $370,500 $370,500
Penta (NVS) $44,010,909 $44,010,909 $44,322,114 101%
Pneumo (NVS) $80,501,916 $80,501,916 $87,829,168 109%
Product Switch Grant (PSG) $211,195 $211,195 $211,195 100%
Rotavirus (NVS) $20,079,579 $20,079,579 $19,343,722 96%
Tetra DTP-HepB (NVS) $13,792,698 $13,792,698 $13,792,698 100%
Vaccine Introduction Grant (VIG) $2,996,337 $2,996,337 $2,256,500 75%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Madagascar DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 90%
M:F sex ratio at birth (2018) 1.03
Household survey: DTP3 coverage for male (2008) 72.60%
Household survey: DTP3 coverage for female (2008) 73.00%
Household survey: Last DTP3 survey (2008) 73%
% districts achieving > 80% DTP3 coverage (2017) 88%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 58%

Breakdown of support

Non-vaccine support Vaccine support
15% 85%
$29,413,598 $173,058,480

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Madagascar

03 April 2019

mozambique

Cholera vaccination campaign begins in Mozambique

Following Cyclone Idai devastation, nearly 900,000 people will receive the vaccine from the Gavi-funded stockpile.

27 March 2019

Gavi item

Leadership training for supply chain managers expands to five African countries

Over 22 private sector partners will support the innovative training and mentorship programme.

24 April 2015

Lions Club WIW

Lions Clubs mobilise for World Immunization Week

Advocacy toolkit launched to help Health Ministries spread the word about vaccination against measles and rubella in developing countries.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here